{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-23-037567","form_type":"8-K","ticker":"VCEL","cik":"0000887359","company_name":"Vericel Corp","filed_at":"2023-11-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:32.265808+00:00","generated_at":"2026-06-08T12:31:51.335518+00:00","sec_items":["9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Vericel reports Q3 2023 revenue of $45.6M (+18% YoY), raises FY guidance","bullets":["Total revenue $45.6M (+18% YoY); MACI revenue $37.6M (+21% YoY).","Net loss $3.7M ($0.08/sh); adjusted EBITDA $5.4M (12% of revenue).","FY2023 revenue guidance raised to $192.5-197.5M from prior $190-197M.","Cash $149M, no debt; 13th consecutive quarter of positive adjusted EBITDA and operating cash flow.","MACI arthroscopic delivery launch expected H1 2024; NexoBrid commercially launched."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-23-037567","json":"https://secwatch.observer/filing/0001628280-23-037567.json","markdown":"https://secwatch.observer/filing/0001628280-23-037567.md","text":"https://secwatch.observer/filing/0001628280-23-037567.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/887359/000162828023037567/0001628280-23-037567-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/887359/000162828023037567/vcel-20231108.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T12:31:51.335518+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}